Late Onset Infection of Pneumocystis jirovecii Infection in a Renal Transplant Recipient.
10.4285/jkstn.2015.29.4.242
- Author:
Dong Han KIM
1
;
Hee Yeoun KIM
;
Jeong Hee YUN
;
Doo Youp KIM
;
Hyun Do JUNG
;
Jin Ho LEE
;
Joon Seok OH
;
Seong Min KIM
;
Young Hun SIN
;
Joong Kyung KIM
Author Information
1. Department of Internal Medicine, Bong Seng Memorial Hospital, Busan, Korea. kidney119@hotmail.com
- Publication Type:Case Report
- Keywords:
Kidney transplantation;
Pneumonia;
Pneumocystis jirovecii;
infection
- MeSH:
Anoxia;
Cough;
Dyspnea;
Fever;
Humans;
Immunosuppressive Agents;
Incidence;
Kidney Transplantation;
Opportunistic Infections;
Pneumocystis jirovecii*;
Pneumocystis*;
Pneumonia;
Transplantation*;
Trimethoprim, Sulfamethoxazole Drug Combination
- From:The Journal of the Korean Society for Transplantation
2015;29(4):242-246
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Pneumocystis jirovecii pneumonia (PCP) can be a life-threatening opportunistic infection after kidney transplantation, occurring most frequently in the first 12 months with the symptoms of dyspnea, cough, fever, and hypoxia. Prophylaxis for PCP is usually applied during the first 3 months to 1 year after transplantation, but late onset incidence of PCP can be detected. We report on a patient who developed PCP 9 years after renal transplantation. The patient showed indolent onset of acute respiratory distress and was treated with trimethoprim-sulfamethoxazole and corticosteroid therapy. Previous rescue treatment of acute cellular rejection with ongoing maintenance of an elevated level of immunosuppressants may have predisposed the patient to PCP.
